Moreover, the SGO2 mRNA expression was grater in WHO grade III gliomas then in grade II gliomas (p = 1.43 × 10–13, p adjusted by Bonferroni method) (Fig. 1b). The gene discussed is SGO2; the disease is central nervous system cancer.